Direct inhibition of human RANK + osteoclast precursors identifies a homeostatic function of IL-1β

Bitnara Lee, Tae Hwan Kim, Jae Bum Jun, Dae Hyun Yoo, Jin Hyun Woo, Sungjae Choi, Young Ho Lee, Gwan Gyu Song, Jeongwon Sohn, Kyung Hyun Park-Min, Lionel B. Ivashkiv, Jong Dae Ji

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

IL-1β is a key mediator of bone resorption in inflammatory settings, such as rheumatoid arthritis (RA). IL-1β promotes osteoclastogenesis by inducing RANKL expression on stromal cells and synergizing with RANKL to promote later stages of osteoclast differentiation. Because IL-1Rs share a cytosolic Toll-IL-1R domain and common intracellular signaling molecules with TLRs that can directly inhibit early steps of human osteoclast differentiation, we tested whether IL-1β also has suppressive properties on osteoclastogenesis in primary human peripheral blood monocytes and RA synovial macrophages. Early addition of IL-1β, prior to or together with RANKL, strongly inhibited human osteoclastogenesis as assessed by generation of TRAP + multinucleated cells. IL-1β acted directly on human osteoclast precursors (OCPs) to strongly suppress expression of RANK, of the costimulatory triggering receptor expressed on myeloid cells 2 receptor, and of the B cell linker adaptor important for transmitting RANK-induced signals. Thus, IL-1β rendered early-stage human OCPs refractory to RANK stimulation. Similar inhibitory effects of IL-1β were observed using RA synovial macrophages. One mechanism of RANK inhibition was IL-1β-induced proteolytic shedding of the M-CSF receptor c-Fms that is required for RANK expression. These results identify a homeostatic function of IL-1β in suppressing early OCPs that contrasts with its well-established role in promoting later stages of osteoclast differentiation. Thus, the rate of IL-1-driven bone destruction in inflammatory diseases, such as RA, can be restrained by its direct inhibitory effects on early OCPs to limit the extent of inflammatory osteolysis.

Original languageEnglish
Pages (from-to)5926-5934
Number of pages9
JournalJournal of Immunology
Volume185
Issue number10
DOIs
Publication statusPublished - 2010 Nov 15

Fingerprint

Osteoclasts
Interleukin-1
Rheumatoid Arthritis
Osteogenesis
Macrophages
Macrophage Colony-Stimulating Factor Receptors
Osteolysis
Myeloid Cells
Bone Resorption
Stromal Cells
Monocytes
B-Lymphocytes
Bone and Bones

ASJC Scopus subject areas

  • Immunology

Cite this

Direct inhibition of human RANK + osteoclast precursors identifies a homeostatic function of IL-1β. / Lee, Bitnara; Kim, Tae Hwan; Jun, Jae Bum; Yoo, Dae Hyun; Woo, Jin Hyun; Choi, Sungjae; Lee, Young Ho; Song, Gwan Gyu; Sohn, Jeongwon; Park-Min, Kyung Hyun; Ivashkiv, Lionel B.; Ji, Jong Dae.

In: Journal of Immunology, Vol. 185, No. 10, 15.11.2010, p. 5926-5934.

Research output: Contribution to journalArticle

Lee, Bitnara ; Kim, Tae Hwan ; Jun, Jae Bum ; Yoo, Dae Hyun ; Woo, Jin Hyun ; Choi, Sungjae ; Lee, Young Ho ; Song, Gwan Gyu ; Sohn, Jeongwon ; Park-Min, Kyung Hyun ; Ivashkiv, Lionel B. ; Ji, Jong Dae. / Direct inhibition of human RANK + osteoclast precursors identifies a homeostatic function of IL-1β. In: Journal of Immunology. 2010 ; Vol. 185, No. 10. pp. 5926-5934.
@article{0756c62737174bb4bdc341602dbf5d31,
title = "Direct inhibition of human RANK + osteoclast precursors identifies a homeostatic function of IL-1β",
abstract = "IL-1β is a key mediator of bone resorption in inflammatory settings, such as rheumatoid arthritis (RA). IL-1β promotes osteoclastogenesis by inducing RANKL expression on stromal cells and synergizing with RANKL to promote later stages of osteoclast differentiation. Because IL-1Rs share a cytosolic Toll-IL-1R domain and common intracellular signaling molecules with TLRs that can directly inhibit early steps of human osteoclast differentiation, we tested whether IL-1β also has suppressive properties on osteoclastogenesis in primary human peripheral blood monocytes and RA synovial macrophages. Early addition of IL-1β, prior to or together with RANKL, strongly inhibited human osteoclastogenesis as assessed by generation of TRAP + multinucleated cells. IL-1β acted directly on human osteoclast precursors (OCPs) to strongly suppress expression of RANK, of the costimulatory triggering receptor expressed on myeloid cells 2 receptor, and of the B cell linker adaptor important for transmitting RANK-induced signals. Thus, IL-1β rendered early-stage human OCPs refractory to RANK stimulation. Similar inhibitory effects of IL-1β were observed using RA synovial macrophages. One mechanism of RANK inhibition was IL-1β-induced proteolytic shedding of the M-CSF receptor c-Fms that is required for RANK expression. These results identify a homeostatic function of IL-1β in suppressing early OCPs that contrasts with its well-established role in promoting later stages of osteoclast differentiation. Thus, the rate of IL-1-driven bone destruction in inflammatory diseases, such as RA, can be restrained by its direct inhibitory effects on early OCPs to limit the extent of inflammatory osteolysis.",
author = "Bitnara Lee and Kim, {Tae Hwan} and Jun, {Jae Bum} and Yoo, {Dae Hyun} and Woo, {Jin Hyun} and Sungjae Choi and Lee, {Young Ho} and Song, {Gwan Gyu} and Jeongwon Sohn and Park-Min, {Kyung Hyun} and Ivashkiv, {Lionel B.} and Ji, {Jong Dae}",
year = "2010",
month = "11",
day = "15",
doi = "10.4049/jimmunol.1001591",
language = "English",
volume = "185",
pages = "5926--5934",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "10",

}

TY - JOUR

T1 - Direct inhibition of human RANK + osteoclast precursors identifies a homeostatic function of IL-1β

AU - Lee, Bitnara

AU - Kim, Tae Hwan

AU - Jun, Jae Bum

AU - Yoo, Dae Hyun

AU - Woo, Jin Hyun

AU - Choi, Sungjae

AU - Lee, Young Ho

AU - Song, Gwan Gyu

AU - Sohn, Jeongwon

AU - Park-Min, Kyung Hyun

AU - Ivashkiv, Lionel B.

AU - Ji, Jong Dae

PY - 2010/11/15

Y1 - 2010/11/15

N2 - IL-1β is a key mediator of bone resorption in inflammatory settings, such as rheumatoid arthritis (RA). IL-1β promotes osteoclastogenesis by inducing RANKL expression on stromal cells and synergizing with RANKL to promote later stages of osteoclast differentiation. Because IL-1Rs share a cytosolic Toll-IL-1R domain and common intracellular signaling molecules with TLRs that can directly inhibit early steps of human osteoclast differentiation, we tested whether IL-1β also has suppressive properties on osteoclastogenesis in primary human peripheral blood monocytes and RA synovial macrophages. Early addition of IL-1β, prior to or together with RANKL, strongly inhibited human osteoclastogenesis as assessed by generation of TRAP + multinucleated cells. IL-1β acted directly on human osteoclast precursors (OCPs) to strongly suppress expression of RANK, of the costimulatory triggering receptor expressed on myeloid cells 2 receptor, and of the B cell linker adaptor important for transmitting RANK-induced signals. Thus, IL-1β rendered early-stage human OCPs refractory to RANK stimulation. Similar inhibitory effects of IL-1β were observed using RA synovial macrophages. One mechanism of RANK inhibition was IL-1β-induced proteolytic shedding of the M-CSF receptor c-Fms that is required for RANK expression. These results identify a homeostatic function of IL-1β in suppressing early OCPs that contrasts with its well-established role in promoting later stages of osteoclast differentiation. Thus, the rate of IL-1-driven bone destruction in inflammatory diseases, such as RA, can be restrained by its direct inhibitory effects on early OCPs to limit the extent of inflammatory osteolysis.

AB - IL-1β is a key mediator of bone resorption in inflammatory settings, such as rheumatoid arthritis (RA). IL-1β promotes osteoclastogenesis by inducing RANKL expression on stromal cells and synergizing with RANKL to promote later stages of osteoclast differentiation. Because IL-1Rs share a cytosolic Toll-IL-1R domain and common intracellular signaling molecules with TLRs that can directly inhibit early steps of human osteoclast differentiation, we tested whether IL-1β also has suppressive properties on osteoclastogenesis in primary human peripheral blood monocytes and RA synovial macrophages. Early addition of IL-1β, prior to or together with RANKL, strongly inhibited human osteoclastogenesis as assessed by generation of TRAP + multinucleated cells. IL-1β acted directly on human osteoclast precursors (OCPs) to strongly suppress expression of RANK, of the costimulatory triggering receptor expressed on myeloid cells 2 receptor, and of the B cell linker adaptor important for transmitting RANK-induced signals. Thus, IL-1β rendered early-stage human OCPs refractory to RANK stimulation. Similar inhibitory effects of IL-1β were observed using RA synovial macrophages. One mechanism of RANK inhibition was IL-1β-induced proteolytic shedding of the M-CSF receptor c-Fms that is required for RANK expression. These results identify a homeostatic function of IL-1β in suppressing early OCPs that contrasts with its well-established role in promoting later stages of osteoclast differentiation. Thus, the rate of IL-1-driven bone destruction in inflammatory diseases, such as RA, can be restrained by its direct inhibitory effects on early OCPs to limit the extent of inflammatory osteolysis.

UR - http://www.scopus.com/inward/record.url?scp=78650661468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650661468&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1001591

DO - 10.4049/jimmunol.1001591

M3 - Article

C2 - 20935210

AN - SCOPUS:78650661468

VL - 185

SP - 5926

EP - 5934

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 10

ER -